Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - oral liquid, solution - excipient ingredients: sodium thiosulfate pentahydrate; water for injections; sodium bicarbonate - sodium iodide (131i) solution bp (for therapy) is indicated in the treatment of hyperthyroidism's and the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 1201 mbq - oral liquid, solution - excipient ingredients: sodium bicarbonate; sodium thiosulfate pentahydrate; water for injections - .

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 20000 mbq/ml - oral liquid, solution - excipient ingredients: sodium bicarbonate; sodium thiosulfate pentahydrate; water for injections - sodium iodide (131i) solution is indicated in the treatment of hypesthysoidism and the detection and abletion of residual functioning thyroid tissue in differentiated throid calcinoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 200 mbq/ml - injection, solution - excipient ingredients: sodium thiosulfate pentahydrate; sodium chloride; water for injections; dibasic sodium phosphate heptahydrate; monobasic sodium phosphate dihydrate - hyperthyroidisms. the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium iodide(131i); sodium iodide (131i) -

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium iodide(131i); sodium iodide ( 131i) -

Singapore - English - HSA (Health Sciences Authority)

quantum technologies global pte. ltd. - sodium iodide na131i, solution - capsule - sodium iodide na131i, solution 37-5500 mbq

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

institute of isotopes co. ltd. - 131i sodium iodide - capsules hard - 38-7400mbq

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - capsule, hard - excipient ingredients: dibasic sodium phosphate; titanium dioxide; iron oxide yellow; water for injections; sodium bicarbonate; sodium thiosulfate pentahydrate; gelatin; sodium lauryl sulfate; silicon dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - .

Israel - English - Ministry of Health

eldan electronic instruments co ltd, israel - sodium iodide (131 i) - hard capsule - sodium iodide (131 i) 37 - 5550 mbq - sodium iodide (131i) - sodium iodide (131i) - theracap 131 is a radioiodine thyroid therapy indicated for:1.treatment of grave's disease, toxic multinodular goitre or autonomous nodules.2.treatmernt of papilary and follicular thyroid carcinoma including metastastic desease.